Pathfinder Cell Therapy Net Tangible Assets

Pathfinder Cell Therapy (PFND) currently reports a net tangible assets of $-6.7M as of September 2015. That compares with $-5.7M in the prior-year period — down 19.1% year over year. Use the charts on this page to explore Pathfinder Cell Therapy's net tangible assets history and peer comparisons.

Pathfinder Cell Therapy's net tangible assets decreased from $-5.7M to $-6.7M — a 19.1% year-over-year decrease (period ending September 2015). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pathfinder Cell Therapy reported $-6.7M in net tangible assets as of September 2015. That compares with $-5.7M in the prior-year period — down 19.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-6.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pathfinder Cell Therapy, and consider following PFND for alerts when major investors trade the stock.

Pathfinder Cell Therapy is classified in the Healthcare sector. On net tangible assets, it currently shows $-6.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PFND with unrelated industries.